MedTrace Logo

AgingUP: A Pilot Program to Reduce Self-Ageism and Self-Stigma in Older Adults With Severe Mental Illness

NCT07690098 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-08-28

No results posted yet for this study

Summary

The goal of this pilot clinical trial is to learn whether AgingUP, a 10-session psychosocial program, helps reduce self-ageism and self-stigma and fosters more positive and realistic views of aging in older adults (≥50 years) living with severe mental illness.

The main questions it aims to answer are:

* Does participation in AgingUP reduce self-directed ageism compared to usual care?
* Does it reduce internalized stigma related to mental illness?
* Does it increase self-compassion?
* Does it improve their perception of their own aging? Researchers will compare the AgingUP group with a control group receiving treatment as usual to see if participants in AgingUP show more adaptive perceptions of aging and self-concept.

Participants will:

* Attend 10 weekly group sessions (60-75 min each) focused on cognitive-behavioral techniques, acceptance and commitment strategies, self-compassion exercises, and empowerment (as a transversal element).
* Complete brief questionnaires about their experiences and attitudes before and after the program.

Conditions

  • Mental Disorder

Interventions

BEHAVIORAL

AgingUP (Self-Ageism Reduction Program)

AgingUP is a 10-session psychosocial group intervention combining Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy (ACT), self-compassion training, and positive narrative work. Sessions focus on identifying and changing negative beliefs about aging and mental illness and on promoting more positive and realistic views of aging. It is delivered in addition to the treatment as usual provided at the participants' center.

Sponsors & Collaborators

  • Universidad Pontificia Comillas

    lead OTHER

Principal Investigators

  • Macarena Sánchez-Izquierdo, PhD · Universidad Pontificia Comillas

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-19
Primary Completion
2025-12-17
Completion
2025-12-17

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07690098 on ClinicalTrials.gov